Analystreport

Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its "hold" rating re-affirmed by analysts at Maxim Group. They now have a $15.50 price target on the stock.

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com